PLATINUM SENSITIVE OVARIAN CANCER
Clinical trials for PLATINUM SENSITIVE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM SENSITIVE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM SENSITIVE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer? experimental drug IMGN151 enters Mid-Stage trials
Disease control Recruiting nowThis study tests an experimental drug called IMGN151 for people with gynecologic cancers, including ovarian cancer. The drug is given alone or with other cancer treatments to see if it is safe and works. About 377 adults will take part at sites worldwide. The goal is to find bett…
Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New hope for ovarian cancer: Rina-S combo trial launches
Disease control Recruiting nowThis study tests whether adding the experimental drug Rina-S to standard therapy helps keep ovarian cancer from coming back. About 528 people with platinum-sensitive ovarian cancer will receive either Rina-S alone, Rina-S plus bevacizumab, bevacizumab alone, or monitoring only. T…
Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated May 07, 2026 18:42 UTC